Acid-sensitive oxidative stress inducing and photoabsorbing polysaccharide nanoparticles for combinational anticancer therapy.

Combination therapy, a treatment regimen that combines more than two therapeutic agents to diseased tissues has recently gained increasing attentions in anticancer therapy. As cancer cells are more vulnerable to oxidative stress and heat compared to normal cells, we developed hyperthermia- and oxidative stress-inducing maltodextrin (HTOM) nanoparticles as a platform of combinational photothermal/oxidative anticancer therapy. HTOM was designed to incorporate cinnamaldehyde as an oxidative stress inducer through acid-labile acetal linkage and IR780 as a photoabsorber. HTOM nanoparticles could generate excess reactive oxygen species (ROS) to kill cancer cells effectively. When exposed to near infrared (NIR) laser irradiation (808 nm), HTOM nanoparticles also increased temperature to destroy cancer cells. The combination of NIR laser irradiation with HTOM nanoparticles exhibited significantly higher anticancer activity than HTOM nanoparticles alone and NIR lasers irradiation alone. When combined with NIR laser irradiation on the tumor site, intravenously administrated HTOM nanoparticles effectively eradicated tumors in mouse xenograft models. Our strategy for combination of oxidative stress and photothermal heating may offer a new combinational treatment modality for cancer.